2
Jul, 2019
16th International course on Dengue, Zika and other emergent arboviruses
The 16th International Course on Dengue, Zika and Other Emergent Arboviruses will take place in Havana, Cuba on August 12 – 23, 2019.
Meetings and events
4
Jun, 2018
International Symposium on Zika Virus Research in Marseille – France
Registrations are now open for the international conference on Zika Virus to be held in Marseille, France, next June. The event – organized by the EU-funded ZIKAlliance project in collaboration with three other EU-funded Zika projects (ZikaPLAN, ZIKAction, and ZIKAVAX) and the European Society for Virology – will take place at the Faculty of Medicine La Timone. The event will provide an overview of the current status of Zika research – covering from basic to clinical research, epidemiology, environmental studies and social sciences – and an opportunity to present the latest results […]
15
Feb, 2018
What we know and what we don’t know about perinatal Zika virus infection: a systematic review
Authors: Soriano-Arandes A, Rivero-Calle I, Nastouli E, et al. Published in: Expert Rev Anti Infect Ther. 2018;16(3):243-254 Introduction: Zika virus (ZIKV) infection has caused the most challenging worldwide infectious epidemic outbreak in recent months. ZIKV causes microcephaly and other congenital malformations. There is a need to perform updated systematic reviews on ZIKV infection periodically because this epidemic is bringing up new evidence with extraordinary speed. Areas covered: Evidence related to ZIKV infection in the gestational, perinatal, and early infant periods covering epidemiology, virology, pathogenesis, risk factors, time of infection during pregnancy, newborn symptoms, treatment, […]
27
Nov, 2017
ZIKAction: approval of the Congenital Microcephaly Case-Control Study protocol
The Ethics Committee of the Universidad Central del Ecuador formally approved the ZIKAction Congenital Microcephaly Case-Control Study protocol.
10
Nov, 2017
Great news from Gainesville, FL (US): the 2° Consortium meeting of our ZIKAction project was a success!
About 70 scientists from 18 countries attended this two-day meeting, which was an outstanding opportunity to
17
Jan, 2013
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children
Here have been no paediatric randomised trials describing the effect of planned treatment interruptions (PTIs) of antiretroviral therapy (ART) on adherence, or evaluating acceptability of such a strategy. In PENTA 11, HIV-infected children were randomised to CD4-guided PTIs (n = 53) or continuous therapy (CT, n = 56). Carers, and children if appropriate, completed questionnaires on adherence to ART and acceptability of PTIs. There was no difference in reported adherence on ART between CT and PTI groups.